Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jermendy

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1986
Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndromeG Jermendy, A Kónya, P Kárpáti
Orvosi Hetilap|October 1, 1995
[Experience with microbiological studies of the diabetic foot]M Kajetán, T M Konkoly, G Jermendy
Acta Diabetologica Latina|October 1, 1990
QT interval prolongation in type 2 (non-insulin-dependent) diabetic patients with cardiac autonomic neuropathyG Jermendy, M Z Koltai, G Pogátsa
Diabetes Care|October 27, 2001
Education level and clustering of clinical characteristics of metabolic syndromeT Hídvégi, K Hetyési, L Bíró, et al.
Experimental and Clinical Endocrinology|December 1, 1988
Serum fructosamine (alkaline-reducing activity) for evaluation of glycemic control in diabetic patientsG Jermendy, J Szelényi, A Bodonyi, et al.
Diabetes, Nutrition & Metabolism|December 6, 2000
Endothelial nitric oxide in diabetes mellitus: too much or not enough?K Farkas, B Sármán, G Jermendy, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 24, 2004
Prevalence of the metabolic syndrome in hypertensive and/or obese subjectsG Jermendy, K Hetyési, L Bíró, et al.
Diabetes, Nutrition & Metabolism|September 1, 2004
Is it time to use the new lower limit of impaired fasting glucose (IFG) among the ATP III criteria for diagnosis of the metabolic syndrome? Prevalence rate of the metabolic syndrome using old and new lower limits of IFG in obese and/or hypertensive subjectsG Jermendy, T Hidvégi, K Hetyési, et al.
Orvosi Hetilap|September 15, 2001
[Advanced microangiopathic complications at the diagnosis of diabetes mellitus]G Pátkai, K Farkas, J Hegedús, et al.
British Journal of Urology|July 1, 1988
Giant congenital hydronephrosis with fatal thromboembolic complication in an adultG Jermendy, A Ivanyi, P Kárpáti, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1986
Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndromeG Jermendy, A Kónya, P Kárpáti
Orvosi Hetilap|October 1, 1995
[Experience with microbiological studies of the diabetic foot]M Kajetán, T M Konkoly, G Jermendy
Acta Diabetologica Latina|October 1, 1990
QT interval prolongation in type 2 (non-insulin-dependent) diabetic patients with cardiac autonomic neuropathyG Jermendy, M Z Koltai, G Pogátsa
Diabetes Care|October 27, 2001
Education level and clustering of clinical characteristics of metabolic syndromeT Hídvégi, K Hetyési, L Bíró, et al.
Experimental and Clinical Endocrinology|December 1, 1988
Serum fructosamine (alkaline-reducing activity) for evaluation of glycemic control in diabetic patientsG Jermendy, J Szelényi, A Bodonyi, et al.
Diabetes, Nutrition & Metabolism|December 6, 2000
Endothelial nitric oxide in diabetes mellitus: too much or not enough?K Farkas, B Sármán, G Jermendy, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 24, 2004
Prevalence of the metabolic syndrome in hypertensive and/or obese subjectsG Jermendy, K Hetyési, L Bíró, et al.
Diabetes, Nutrition & Metabolism|September 1, 2004
Is it time to use the new lower limit of impaired fasting glucose (IFG) among the ATP III criteria for diagnosis of the metabolic syndrome? Prevalence rate of the metabolic syndrome using old and new lower limits of IFG in obese and/or hypertensive subjectsG Jermendy, T Hidvégi, K Hetyési, et al.
Orvosi Hetilap|September 15, 2001
[Advanced microangiopathic complications at the diagnosis of diabetes mellitus]G Pátkai, K Farkas, J Hegedús, et al.
British Journal of Urology|July 1, 1988
Giant congenital hydronephrosis with fatal thromboembolic complication in an adultG Jermendy, A Ivanyi, P Kárpáti, et al.
Pageof 8